CI-960 (PD127391 or AM-1091), sparfloxacin, WIN 57273, and isepamicin activity against clinical isolates of Mycobacterium avium-intracellularae complex, M. chelonae, and M. fortuitum (Q28343123)

From Wikidata

Jump to navigation Jump to search

scientific article (publication date: February 1992)

Language	Label	Description	Also known as
English	CI-960 (PD127391 or AM-1091), sparfloxacin, WIN 57273, and isepamicin activity against clinical isolates of Mycobacterium avium-intracellularae complex, M. chelonae, and M. fortuitum	scientific article (publication date: February 1992)

Statements

scholarly article

0 references

CI-960 (PD127391 or AM-1091), sparfloxacin, WIN 57273, and isepamicin activity against clinical isolates of Mycobacterium avium-intracellularae complex, M. chelonae, and M. fortuitum (English)

0 references

Mycobacterium chelonae

1 reference

based on heuristic

inferred from title

Mycobacterium avium avium

1 reference

based on heuristic

inferred from title

Meridith E. Erwin

3

object named as

M. E. Erwin

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1315233

12 September 2022

author name string

M. S. Barrett

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1315233

12 September 2022

R. N. Jones

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1315233

12 September 2022

F. P. Koontz

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1315233

12 September 2022

language of work or name

0 references

publication date

February 1992

0 references

full work available at URL

https://api.elsevier.com/content/article/PII:073288939290044T?httpAccept=text/xml

1 reference

10.1016/0732-8893(92)90044-T

https://api.crossref.org/works/10.1016/0732-8893(92)90044-T

3 December 2023

https://api.elsevier.com/content/article/PII:073288939290044T?httpAccept=text/plain

1 reference

10.1016/0732-8893(92)90044-T

https://api.crossref.org/works/10.1016/0732-8893(92)90044-T

3 December 2023

Diagnostic Microbiology and Infectious Disease

0 references

15

0 references

2

0 references

169-71

0 references

Amikacin, ethambutol, and rifampin for treatment of disseminated Mycobacterium avium-intracellulare infections in patients with acquired immune deficiency syndrome

1

1 reference

10.1016/0732-8893(92)90044-T

https://api.crossref.org/works/10.1016/0732-8893(92)90044-T

3 December 2023

Effect of ciprofloxacin on intracellular organisms: in-vitro and in-vivo studies

2

1 reference

10.1016/0732-8893(92)90044-T

https://api.crossref.org/works/10.1016/0732-8893(92)90044-T

3 December 2023

In vitro activity of sparfloxacin (AT-4140, CI-978, PD 131501), a new quinolone antimicrobial agent

3

1 reference

10.1016/0732-8893(92)90044-T

https://api.crossref.org/works/10.1016/0732-8893(92)90044-T

3 December 2023

In vivo activity of amikacin alone or in combination with clofazimine or rifabutin or both against acute experimental Mycobacterium avium complex infections in beige mice

4

1 reference

10.1016/0732-8893(92)90044-T

https://api.crossref.org/works/10.1016/0732-8893(92)90044-T

3 December 2023

MIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven antituberculosis drugs

5

1 reference

10.1016/0732-8893(92)90044-T

https://api.crossref.org/works/10.1016/0732-8893(92)90044-T

3 December 2023

Comparison of bactericidal activities of streptomycin, amikacin, kanamycin, and capreomycin against Mycobacterium avium and M. tuberculosis

6

1 reference

10.1016/0732-8893(92)90044-T

https://api.crossref.org/works/10.1016/0732-8893(92)90044-T

3 December 2023

Determination of in vitro susceptibility of Mycobacterium avium complex isolates to antimycobacterial agents by various methods

7

1 reference

10.1016/0732-8893(92)90044-T

https://api.crossref.org/works/10.1016/0732-8893(92)90044-T

3 December 2023

Biological activity of SCH 21420, the 1-N-S-alpha-hydroxy-beta-aminopropionyl derivative of gentamicin B

8

1 reference

10.1016/0732-8893(92)90044-T

https://api.crossref.org/works/10.1016/0732-8893(92)90044-T

3 December 2023

Mycobacterial disease in patients with human immunodeficiency virus infection

9

1 reference

10.1016/0732-8893(92)90044-T

https://api.crossref.org/works/10.1016/0732-8893(92)90044-T

3 December 2023

In vitro and in vivo antibacterial activities of AT-4140, a new broad-spectrum quinolone

10

1 reference

10.1016/0732-8893(92)90044-T

https://api.crossref.org/works/10.1016/0732-8893(92)90044-T

3 December 2023

Mycobacteria other than Mycobacterium tuberculosis: review of microbiologic and clinical aspects

13

1 reference

10.1016/0732-8893(92)90044-T

https://api.crossref.org/works/10.1016/0732-8893(92)90044-T

3 December 2023

In vitro susceptibility of Mycobacterium avium complex to the new fluoroquinolone sparfloxacin (CI-978; AT-4140) and comparison with ciprofloxacin

14

1 reference

10.1016/0732-8893(92)90044-T

https://api.crossref.org/works/10.1016/0732-8893(92)90044-T

3 December 2023

Identifiers

10.1016/0732-8893(92)90044-T

0 references

release_kcuwp7vbdjdrxdg3qf32xwqxra

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28343123&oldid=2023375284"